UNSPSC 51162718: Guaiacol nicotinate

This classification denotes a topical anti-infective agent and expectorant with the molecular formula C13H11NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0NL78157RR. Most nations, for tariff and trade purposes, schedule guaiacol nicotinate under HS 29095000 and SITC 51617. As of Q4 2014, GUAIACOL NICOTINATE remains US FDA's Preferred Term for this commodity. SMILES: COC1CCCCC1OC(=O)C2CCCNC2.

UNSPSC 51162718 Guaiacol nicotinate is a Commodity code that nominally describes a single pharmaceutical compound, but state and local procurement activity under this code does not reflect purchases of guaiacol nicotinate specifically. Recent solicitations tagged to this code instead cover parenteral products and equipment — intravenous solutions, parenteral nutrition preparations (TPN and PPN), and related delivery services — and opioid-reversal pharmaceuticals with associated disposal systems. The Washington State Department of Corrections' RFQ for parenteral products and services reflects the primary pattern: state correctional systems and health departments procure IV solutions, compounded nutrition bags, injectable medications, and the logistics infrastructure to deliver them within tight windows (24 hours for nutrition formulations, 8 hours for other parenteral stock). The issuing bodies are state agencies and county health authorities, each managing supplies for incarcerated populations or community health programs. Set-aside designations appear in the DOC solicitation, with aspirational targets for small business (25%), minority-owned business (10%), women-owned business (6%), and veteran-owned business (5%) participation under Washington State's utilization rules.

Washington and Florida have generated the most recent activity. The Washington State Department of Corrections posted RFQ RFQQK13020 on September 8, 2026, due October 7, 2026, for parenteral products and services across eight facilities spanning three regions (West, Central, and East), with contract award to multiple vendors and a term running November 26, 2026 through June 30, 2030. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, requesting 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, though that posting's due date of July 26, 2023 appears dated and may reflect a clerical error in the source. Neither solicitation explicitly references guaiacol nicotinate as a line item, indicating that the code's nominal scope diverges from actual state and local buying patterns under it.